Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to determine whether the amount of radiation given to the normal areas around the anal cancer can be reduced by using Proton Therapy while reducing the side effects that are seen with standard therapy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03018418
Study type Interventional
Source University of Cincinnati
Contact
Status Active, not recruiting
Phase Phase 2
Start date January 4, 2017
Completion date July 2024

See also
  Status Clinical Trial Phase
Completed NCT01717391 - [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers Phase 2
Completed NCT00622440 - Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream Phase 2
Enrolling by invitation NCT02526953 - Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients Phase 3
Recruiting NCT05578820 - Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid Phase 1
Recruiting NCT02384005 - The Feasibility of Self or Partner-assisted Digital Anal Exam Screening N/A
Completed NCT00428285 - Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men Phase 2
Completed NCT00107679 - A Study of Anal Cancer Development in HIV Infected People N/A
Terminated NCT01408407 - Alkagin Paste in the Prevention of Radiation Dermatitis Phase 2
Completed NCT00799474 - Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination N/A
Completed NCT03202992 - Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection Phase 1
Completed NCT00000764 - Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. Phase 1